Any solution will require targeting multiple sources of cost. As you point out elsewhere, R&D is a big cost driver, but profit seems comparable [1]. Moreover on

Any solution will require targeting multiple sources of cost. As you point out elsewhere, R&D is a big cost driver, but profit seems comparable [1]. Moreover one does have to wonder about the various sources of that R&D cost, I'm not an expert but it would seem to me that issues like "evergreening" would inflate development costs unnecessarily. [1] https://healthpolicy.usc.edu/evidence-base/how-did-the-public-u-s-drugmakers-sales-expenses-and-profits-change-over-time https://healthpolicy.usc.edu/evidence-base/how-did-the-publi...